Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04017702 · ClinicalTrials.gov registry record

Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring

A clinical trial, sponsored by Yale University.

Completed
Registry status
86
Enrollment target

NCT04017702 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 86 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04017702 has completed, sponsored by Yale University.

COMPLETED
Registry status
86 participants
Enrollment target

Study Summary

Respiratory volume monitor (RVM) (ExSpiron) is superior to continuous pulse oximetry in detection of postoperative respiratory depression in high risk patients.

Interventions

  • DEVICE Expiron respirator

Trial Details

FieldValue
Enrollment Target 86 participants
Start Date 2018-06-20
Est. Completion 2020-02-20

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04017702

The ClinicalTrials.gov registry entry for NCT04017702 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Expiron respirator is the first listed.

NCT04017702 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04017702 about?

NCT04017702 is a clinical study titled "Detection of Postoperative Respiratory Depression in High Risk Patients Utilizing Minute Ventilation Monitoring". Respiratory volume monitor (RVM) (ExSpiron) is superior to continuous pulse oximetry in detection of postoperative respiratory depression in high risk patients.

What is the current status of trial NCT04017702?

This trial is currently completed. The enrollment target is 86 participants. The study started on 2018-06-20. Estimated completion is 2020-02-20.

What interventions are being tested in trial NCT04017702?

The interventions under investigation include: Expiron respirator (DEVICE).

Who is sponsoring clinical trial NCT04017702?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.